PROACT Xa Trial of Apixaban With On-X Heart Valve Stopped

The DSMB cited a lack of evidence supporting noninferiority of apixaban over warfarin for valve thrombosis and thromboembolism.

Related Keywords

North Carolina ,United States ,Duke University ,John Alexander ,Duke University School Of Medicine ,Artivion Inc ,Duke University School ,Healthcare And Medical Technology ,Ealth And Medical Tech ,Ealth And Med Tech ,Ealth And Medical Technology ,Stroke ,Erebrovascular Accident ,Va Cerebrovascular Accident ,Clinical Research ,Clinical Trials ,Linical Studies ,Thromboembolism ,Thrombosis ,Thrombus ,Valvar Aortic Stenosis ,Aortic Valve Disease ,Anticoagulation Therapy ,Anticoagulant ,Anticoagulation ,